LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1Shanghai Minbiotech
03 1Biotechnica DWC
04 2Celltrion
05 1KinBio
06 2Patheon
07 2Samsung Biologics
01 1Algeria
02 1China
03 1Israel
04 4South Korea
05 3U.S.A
01 10Blank
01 10Blank
01 1225MF10184
02 9Blank
01 10Blank
01 10Blank
01 232228-001
02 168225-072
03 168225-088
04 171124-0004
05 171124-0031
06 4Blank
01 10Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
NDC Package Code : 71124-0031
Start Marketing Date : 2023-07-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 71124-0004
Start Marketing Date : 2018-09-10
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 32228-001
Start Marketing Date : 2016-08-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/10mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
Registration Number : 225MF10184
Registrant's Address : 19, Academy-ro 51beon-gil, Yeonsu-gu, Incheon, 22014, Korea
Initial Date of Registration : 2013-09-25
Latest Date of Registration :
NDC Package Code : 32228-001
Start Marketing Date : 2016-11-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/10mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 68225-072
Start Marketing Date : 1998-08-24
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/10mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 68225-088
Start Marketing Date : 2017-07-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (100mg/10mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
We have 7 companies offering Inflectra
Get in contact with the supplier of your choice:
